SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT)


Werte in diesem Artikel
Aktien

81.32 EUR 1.98 EUR 2.50 %

NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Corcept Therapeutics Incorporated (NASDAQ: CORT) on behalf of the company's shareholders.  The investigation seeks to determine whether Corcept's directors breached their fiduciary duties in connection with recent corporate actions.

Purcell & Lefkowitz LLP (PRNewsfoto/Purcell & Lefkowitz LLP)

If you are a shareholder of Corcept Therapeutics Incorporated and are interested in obtaining additional information regarding your rights and options, free of charge, please visit us at: https://pjlfirm.com/corcept-therapeutics-incorporated/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.  One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com.   Attorney advertising. Prior results do not guarantee a similar outcome. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-purcell--lefkowitz-llp-announces-shareholder-investigation-of-corcept-therapeutics-incorporated-nasdaq-cort-302229991.html

SOURCE Purcell & Lefkowitz LLP

Aktuelle Corcept Therapeutics Aktie News

Werbung

Corcept Therapeutics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Corcept Therapeutics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
04.02.19 Corcept Therapeutics Neutral B. Riley FBR
10.08.18 Corcept Therapeutics Hold Stifel, Nicolaus & Co., Inc.
31.05.18 Corcept Therapeutics Hold Stifel, Nicolaus & Co., Inc.
09.03.18 Corcept Therapeutics Buy B. Riley FBR, Inc.
31.08.17 Corcept Therapeutics Buy Stifel, Nicolaus & Co., Inc.